PolyNovo Limited Stock
Stocks
PNV
AU000000PNV0
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Delayed
Australian S.E.
21:05:09 2026-11-08 EST
|
5-day change | 1st Jan Change | ||
| 0.9125 AUD | +2.53% |
|
+1.10% | -25.61% |
| Market Cap | 615M 423M 379M 347M 316M 596M 39.75B 4.18B 1.67B 21.21B 1.59B 1.55B 66.95B | P/E 2027 * |
63.2x | P/E 2028 * | 33.3x |
|---|---|---|---|---|---|
| Enterprise Value | 575M 395M 355M 324M 296M 557M 37.16B 3.91B 1.56B 19.83B 1.48B 1.45B 62.59B | EV / Sales 2027 * |
3.55x | EV / Sales 2028 * | 3.01x |
| Free-Float |
90.03% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| PNV | Delayed | |
OTC Markets
| CALZ.F | Delayed | |
|
Tradegate
| MFJ | Real-time | |
|
Deutsche Boerse AG
| MFJ | Delayed | |
|
Börse Stuttgart
| MFJ | Delayed | |
|
Boerse Muenchen
| MFJ | Real-time | |
|
Berne S.E.
| MFJ | End-of-day quote |
Last Transcript: PolyNovo Limited
| 25-08-25 | Morgans rates PNV as Speculative Buy | AQ |
| 24-11-25 | Morgans rates PNV as Add | AQ |
| 23-12-07 | Ord Minnett rates PNV as Lighten | AQ |
| 22-04-22 | PolyNovo : Notification regarding unquoted securities - PNV | PU |
| 22-01-23 | PolyNovo : Application for quotation of securities - PNV | PU |
| 1 day | +2.81% | ||
| 1 week | +1.10% | ||
| Current month | +1.10% | ||
| 1 month | -2.14% | ||
| 3 months | -3.17% | ||
| 6 months | -10.29% | ||
| Current year | -25.61% |
| 1 week | 0.87 |  | 0.94 |
| 1 month | 0.84 | | 0.96 |
| Current year | 0.81 | | 1.3 |
| 1 year | 0.81 | | 1.3 |
| 3 years | 0.81 | | 2.78 |
| 5 years | 0.81 | | 2.78 |
| 10 years | 0.17 | | 4.08 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bruce Peatey
CEO | Chief Executive Officer | - | 2025-11-30 |
| Director of Finance/CFO | - | 2018-12-11 | |
Marthe D’Ombrain
CTO | Chief Tech/Sci/R&D Officer | - | 2026-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Leon Hoare
CHM | Chairman | - | 2025-10-26 |
Andrew Lumsden
BRD | Director/Board Member | 48 | 2021-06-03 |
Rob Douglas
BRD | Director/Board Member | 66 | 2025-10-13 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/16/26 | Buy | Director | 151,000 | 0.0219% | ||
| 2/27/26 | Buy | Director | 100,000 | 0.0145% | ||
| 2/27/26 | Buy | Chairman | 30,000 | 0.0043% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.53% | +1.10% | -25.31% | -33.21% | 423M | |
| -3.23% | +3.51% | -13.00% | +16.03% | 190B | |
| -2.90% | +5.45% | +10.41% | +41.96% | 125B | |
| -2.75% | +11.65% | -8.47% | +18.59% | 124B | |
| +0.96% | +5.15% | -37.16% | +11.38% | 99.31B | |
| -1.80% | +0.82% | -7.52% | +69.50% | 63.65B | |
| -0.78% | +7.07% | +19.14% | -17.21% | 57.71B | |
| +0.79% | +22.65% | -4.57% | +58.05% | 53.26B | |
| +3.13% | -6.80% | -7.64% | +48.01% | 47.03B | |
| -2.36% | +3.72% | +3.86% | -7.32% | 36.15B | |
| Average | -0.62% | +4.38% | -7.03% | +20.58% | 79.66B | |
| Weighted average by Cap. | -1.60% | +5.55% | -7.24% | +25.38% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 162M 111M 99.78M 91.19M 83.24M 157M 10.46B 1.1B 438M 5.58B 418M 409M 17.62B | 186M 128M 115M 105M 95.55M 180M 12B 1.26B 503M 6.4B 479M 469M 20.22B |
| Net income | 9.77M 6.72M 6.03M 5.51M 5.03M 9.47M 632M 66.4M 26.48M 337M 25.23M 24.68M 1.06B | 18.5M 12.72M 11.41M 10.43M 9.52M 17.93M 1.2B 126M 50.11M 638M 47.74M 46.72M 2.01B |
| Net Debt | -40.06M -27.54M -24.7M -22.58M -20.61M -38.83M -2.59B -272M -109M -1.38B -103M -101M -4.36B | -55.32M -38.04M -34.12M -31.18M -28.47M -53.63M -3.58B -376M -150M -1.91B -143M -140M -6.02B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-08 | A$0.9125 | +2.53% | 204,626 |
| 26-11-06 | A$0.8900 | -1.66% | 1,062,626 |
| 26-11-05 | A$0.9050 | +3.43% | 1,524,680 |
| 26-11-04 | A$0.8750 | -5.41% | 938,473 |
| 26-11-03 | A$0.9250 | +2.21% | 1,508,147 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PNV Stock
Select your edition
All financial news and data tailored to specific country editions
